TrialClinical and experimental nephrology2016

Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).

Enyu Imai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.